Allergan has announced its decision to shut down by the end of this year the R&D facilities of its French subsidiary, which moved to a new high-tech site in 2002. The measure, which will lead to the layoff of 126 of the company's 195 employees on the premises, has been ...
Buying a membership today will give you:
To continue reading this article register now.